Women's Health and the Cloning Debate
By Elayne Clift,
Womens Feature Service
| 09. 16. 2002
American feminists and women's health activists are debating on the
difficult issue of human cloning and stem cell research. Human cloning
involves creating embryos with the intent of implanting them in women
to produce children. In therapeutic cloning on the other hand, genetic
material from a body cell is inserted into an egg cell, replacing the
nucleus. As the cell begins to divide, scientists believe stem cells
can be extracted and grown into tissue or organs. Thus, a kind of
'regenerative medicine' gives people access to therapies derived from
their own cells.
Last year, the
Republican-controlled House of Representatives in the US Congress
passed a bill banning all human cloning, a measure President Bush
supports. The bill, introduced by Sam Brownback, a Kansas Republican
who has been called "the torchbearer of the Christian Right", called
for a total ban on human cloning, which would also preclude cloning
embryonic stem cells for research purposes, or 'therapeutic cloning'.
In
May 2002, the Senate countered with its own legislation designed to
foster scientific research. Their "Human Cloning Prohibition Act of
2002" would prohibit...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...